This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Koh, W.-J. Search for Related Content PubMed PubMed Citation Articles by Koh, W.-J. Social Bookmarking                            What's this?

Controversies in the Radiotherapeutic Management of Cervical Cancer

Wui-Jin Koh

From the Department of Radiation Oncology, University of Washington Medical Center, Seattle, WA.

Address reprint requests to Wui-Jin Koh, MD, Department of Radiation Oncology, Box 356043 University of Washington Medical Center, 1959 NE Pacific St, Seattle, WA 98195; email: wkoh{at}u.washington.edu.

Radiotherapy is a critical component of treatment for many patients with cervical cancer. The role of concurrent cisplatin-based chemotherapy in the majority of cases where radiotherapy is indicated has been established. However, optimal planning and delivery of radiotherapy require attention to multiple factors beyond combined-modality chemoradiation and the continuing search for novel and effective synergistic systemic agents. Several important issues surrounding radiotherapy for cervical cancer that require clarification include the following: the effect of anemia and tumor hypoxia on outcome and their potential as therapeutic targets, the appropriate incorporation of contemporary imaging and high-technology treatment planning systems in routine clinical practice, the role of prophylactic para-aortic radiation, and the role of radioprotectors. Ongoing and newly proposed studies are expected to provide insights into these questions, which will ultimately lead to enhanced radiotherapeutic and overall care for patients with cervical cancer.

Presented at the conference on Progress in the Management of Gynecologic Cancer, Cambridge, MA, October 25–26, 2002.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?